Fukuoka, Japan

Yoshihiro Tanoue

This inventor holds 2 USPTO granted patents. Top assignee: Hisamitsu Pharmaceutical Company, Inc.. Active years: 1990-1999.


% Patents Active = 100.0

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Fukuoka, JP (1990)
  • Tosu, JP (1999)

Company Filing History:


Years Active: 1990-1999

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Yoshihiro Tanoue

Introduction

Yoshihiro Tanoue is a notable inventor based in Fukuoka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds with therapeutic applications. With a total of 2 patents to his name, Tanoue's work is recognized for its potential impact on medicine.

Latest Patents

One of Tanoue's latest patents includes the development of piperidine derivatives as substance P antagonists. This innovative compound, specifically the 3-aroyl-6,7-dihydro-5H-pyrrolo(1,2-c)imidazole-7-carboxylic acid, is a novel derivative that demonstrates excellent analgesic and anti-inflammatory properties. Importantly, it is noted for having remarkably less toxicity and side effects compared to existing treatments.

Career Highlights

Yoshihiro Tanoue is currently associated with Hisamitsu Pharmaceutical Company, Inc., where he continues to advance his research and development efforts. His work is pivotal in creating new medications that can improve patient outcomes and enhance quality of life.

Collaborations

Throughout his career, Tanoue has collaborated with esteemed colleagues such as Koichi Beppu and Masaru Saita. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Yoshihiro Tanoue's contributions to the field of pharmaceuticals through his innovative patents highlight his commitment to advancing medical science. His work not only showcases his expertise but also reflects the potential for future developments in pain management and anti-inflammatory treatments.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…